This training will provide an overview of the most recent advances and knowledge around the effectiveness of all types of FDA-approved Medications for Opioid Use Disorder (MOUD). New FDA-approved agents for MOUD will be reviewed. There will also be a discussion of how to address co-occurring substance use disorders (alcohol, cocaine, and methamphetamine). Additionally, the latest FDA-approved nasal rescue agents will be reviewed.